FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Martina Skrede

Research Profile

Disorders

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Thea Eline Hetland; Janne Kaern; Berit Sandstad; Martina Skrede; Claes Tropé; Ben Davidson; Vivi Ann Flørenes
Predicting platinum resistance in primary advanced ovarian cancer patients with an in vitro resistance index.
Ana Slipicevic; Kjersti Jørgensen; Martina Skrede; Anne Katrine Ree Rosnes; Gunhild Trøen; Ben Davidson; Vivi Ann Flørenes
The fatty acid binding protein 7 (FABP7) is involved in proliferation and invasion of melanoma cells.
Ben Davidson; Rivka Hadar; Anat Schlossberg; Tamar Sternlicht; Ana Slipicevic; Martina Skrede; Björn Risberg; Vivi Ann Flørenes; Juri Kopolovic; Reuven Reich
Expression and clinical role of DJ-1, a negative regulator of PTEN, in ovarian carcinoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Martina Skrede (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Thea Eline Hetland; Janne Kaern; Berit Sandstad; Martina Skrede; Claes Tropé; Ben Davidson; Vivi Ann Flørenes
Predicting platinum resistance in primary advanced ovarian cancer patients with an in vitro resistance index.
Cancer chemotherapy and pharmacology 2012;69(5):1307-14.
2008: Ana Slipicevic; Kjersti Jørgensen; Martina Skrede; Anne Katrine Ree Rosnes; Gunhild Trøen; Ben Davidson; Vivi Ann Flørenes
The fatty acid binding protein 7 (FABP7) is involved in proliferation and invasion of melanoma cells.
BMC cancer 2008;8():276.
2008: Ben Davidson; Rivka Hadar; Anat Schlossberg; Tamar Sternlicht; Ana Slipicevic; Martina Skrede; Björn Risberg; Vivi Ann Flørenes; Juri Kopolovic; Reuven Reich
Expression and clinical role of DJ-1, a negative regulator of PTEN, in ovarian carcinoma.
Human pathology 2008;39(1):87-95.
2007: Ben Davidson; Martina Skrede; Ilvars Silins; Ie-Ming Shih; Claes G Trope; Vivi Ann Flørenes
Low-molecular weight forms of cyclin E differentiate ovarian carcinoma from cells of mesothelial origin and are associated with poor survival in ovarian carcinoma.
Cancer 2007;110(6):1264-71.
2006: Lilach Kleinberg; Vivi Ann Flørenes; Martina Skrede; Hiep Phuc Dong; Søren Nielsen; Michael T McMaster; Jahn M Nesland; Ie-Ming Shih; Ben Davidson
Expression of HLA-G in malignant mesothelioma and clinically aggressive breast carcinoma.
Virchows Archiv : an international journal of pathology 2006;449(1):31-9.
2005: Kjersti Jørgensen; Martina Skrede; Véronique Cruciani; Svein-Ole Mikalsen; Ana Slipicevic; Vivi Ann Flørenes
Phorbol ester phorbol-12-myristate-13-acetate promotes anchorage-independent growth and survival of melanomas through MEK-independent activation of ERK1/2.
Biochemical and biophysical research communications 2005;329(1):266-74.
2005: Marci E Schaner; Ben Davidson; Martina Skrede; Reuven Reich; Vivi Ann Flørenes; Björn Risberg; Aasmund Berner; Iris Goldberg; Vered Givant-Horwitz; Claes G Tropè; Gunnar Kristensen; Jahn M Nesland; Anne-Lise Børresen-Dale
Variation in gene expression patterns in effusions and primary tumors from serous ovarian cancer patients.
Molecular cancer 2005;4():26.
2004: Vivi Ann Flørenes; Martina Skrede; Kjersti Jørgensen; Jahn M Nesland
Deacetylase inhibition in malignant melanomas: impact on cell cycle regulation and survival.
Melanoma research 2004;14(3):173-81.
2003: Ben Davidson; Reuven Reich; Philip Lazarovici; Jahn M Nesland; Martina Skrede; Björn Risberg; Claes G Tropé; Vivi Ann Flørenes
Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(6):2248-59.
1998: Tone Ikdal Andersen; Hans Geir Eiken; Fergus J. Couch; G Kaada; Martina Skrede; Hilde Johnsen; T A Aloysius; Kjell Magne Tveit; L Tranebjaerg; Anne Dørum; Pål Møller; B L Weber; Anne-Lise Børresen-Dale
Constant denaturant gel electrophoresis (CDGE) in BRCA1 mutation screening.
Human mutation 1998;11(2):166-74.
1997: T I Anderson; Richard Wooster; K Laake; N Collins; William Warren; Martina Skrede; R Elles; Kjell Magne Tveit; S R Johnston; M Dowsett; A O Olsen; Pål Møller; M R Stratton; Anne-Lise Børresen-Dale
Screening for ESR mutations in breast and ovarian cancer patients.
Human mutation 1997;9(6):531-6.
1996: Gunhild M Maelandsmo; Eivind Hovig; Martina Skrede; Olav Engebraaten; Vivi Ann Flørenes; Ola Myklebost; Mariam Grigorian; Eugene Lukanidin; K J Scanlon; Oystein Fodstad
Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme.
Cancer research 1996;56(23):5490-8.
1995: Ketil Heimdal; Tone Ikdal Andersen; Martina Skrede; Sophie D Fosså; K Berg; A L Børresen
Association studies of estrogen receptor polymorphisms in a Norwegian testicular cancer population.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1995;4(2):123-6.
1994: Tone Ikdal Andersen; Ketil Heimdal; Martina Skrede; Kjell Magne Tveit; K Berg; A L Børresen
Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility.
Human genetics 1994;94(6):665-70.
1994: Vivi Ann Flørenes; T Oyjord; Ruth Holm; Martina Skrede; A L Børresen; Jahn M Nesland; Oystein Fodstad
TP53 allele loss, mutations and expression in malignant melanoma.
British journal of cancer 1994;69(2):253-9.
1993: L Ottestad; Tone Ikdal Andersen; Jahn M Nesland; Martina Skrede; Kjell Magne Tveit; Kjell Nustad; A L Børresen
Amplification of c-erbB-2, int-2 and c-myc genes in node-negative breast carcinomas. Relationship to prognosis.
Acta oncologica (Stockholm, Sweden) 1993;32(3):289-94.
1989: L Ottestad; Kjell Magne Tveit; Einar Hannisdal; Martina Skrede; Jahn M Nesland; S Gundersen; A Pihl
Colony forming ability of human breast carcinomas: lack of prognostic significance.
British journal of cancer 1989;60(2):216-9.